Olema Pharmaceuticals Inc (OLMA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Operating Expenses | 37,621 | 33,530 | 34,339 | 30,416 | 23,342 |
| Operating Income | -37,621 | -33,530 | -34,339 | -30,416 | -23,342 |
| Other Income | 3,066 | 3,148 | 3,369 | 3,644 | 1,840 |
| Pre-tax Income | -34,555 | -30,382 | -30,970 | -26,772 | -21,502 |
| Net Income Continuous | -34,555 | -30,382 | -30,970 | -26,772 | -21,502 |
| Net Income | $-34,555 | $-30,382 | $-30,970 | $-26,772 | $-21,502 |
| EPS Basic Total Ops | -0.60 | -0.54 | -0.56 | -0.47 | -0.48 |
| EPS Basic Continuous Ops | -0.60 | -0.54 | -0.56 | -0.46 | -0.48 |
| EPS Diluted Total Ops | -0.60 | -0.54 | -0.56 | -0.47 | -0.48 |
| EPS Diluted Continuous Ops | -0.60 | -0.54 | -0.56 | -0.46 | -0.48 |
| EPS Diluted Before Non-Recurring Items | -0.60 | -0.54 | -0.56 | N/A | N/A |
| EBITDA(a) | $-37,526 | $-33,436 | $-34,251 | $-30,328 | $-23,252 |